Increase in the prevalence of chronic diseases, rise in investments in R&D by pharmaceutical companies, and surge in surgical procedures for ophthalmic, dental and ENT disorders drive the growth
/PRNewswire/ The "Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change" report has.